Some screens miss spread of breast cancer: study

September 12, 2012 by Amanda Gardner, Healthday Reporter
Some screens miss spread of breast cancer: study
Bone scans, liver ultrasounds and chest X-rays only caught small number of cases.

(HealthDay)—In a new study, three types of screening methods used to determine whether breast cancer has spread to other parts of the body only spotted a small portion of tumors that had done so.

This may mean that bone scans, liver ultrasounds and chest X-rays may not have a significant role to play in tracking the stage a breast cancer is at, particularly for tumors that are diagnosed earlier, the researchers added.

"Very low detection rates, particularly for stage I and II breast cancer, really question the utility of these three [techniques]," said study author Stuart-Allison Moffat Staley, a medical student at the University of North Carolina School of Medicine in Chapel Hill.

Moffat Staley presented her findings Tuesday in San Francisco at the 2012 Breast Cancer Symposium, sponsored by the (ASCO).

Extravagant ordering of tests can also result in unnecessary biopsies and anxiety, sometimes resulting in more harm than good, added Dr. Andrew Seidman, a medical oncologist at Memorial Sloan-Kettering Cancer Center in New York City.

Both Moffat Staley and Seidman, who is also an ASCO official, spoke at a Tuesday news conference.

When it spreads, often travels to the bone, liver and lung, hence the use of these particular scans to assess metastases, Moffat Staley explained. These three techniques are significantly less expensive than two other options that are available, CT scans and MRIs, he noted.

Of course, when used in thousands of (some of whom undergo all three scans) the practice becomes costly, not only to the but also to individual patients, she added.

In the research, Moffat Staley combined data from eight studies and found detection rates of only 0.51 percent, 0.82 percent, 2.43 percent for chest X-ray, liver ultrasound and bone scans, respectively.

Detection rates were higher for Stage III cancers: about 4.6 percent, 4.2 percent and 12.5 percent, respectively.

At some point, screening will be needed to make sure there's no metastases, as this will determine what kind of treatment a woman will get, noted Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. She was not involved in the study.

Bone scans, liver ultrasounds and chest X-rays are not necessarily the tests of choice for many doctors. CT scans and PET scans are also often used, Bernik noted.

Moffat Staley stressed that more studies need to be done on this issue, specifically research that compares these three screenings against CT scans, MRIs and PET scans.

Research presented at medical meetings should be considered preliminary because it hasn't undergone the scrutiny of studies published in peer-reviewed journals.

Explore further: Routine follow-up scans can detect head and neck cancer recurrences earlier

More information: The U.S. National Cancer Institute has more on breast cancer.


Related Stories

Routine follow-up scans can detect head and neck cancer recurrences earlier

January 26, 2012
Routine use of positron emission tomography/computed tomography (PET/CT) scans in head and neck cancer patient follow-up can detect local recurrences before they become clinically apparent and may improve the outcome of subsequent ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.